Genomics and Hematologic Malignancies: Beyond the Philadelphia Chromosome
- Available: June 24, 2021 —
- June 30, 2021
- Credit: 1.5hr(s)
- Credit Types: NCPD, Nurse Practitioners, Social Worker
- Therapeutic Areas: Genomics
- Location: Internet Activity Enduring Material
It has been 60 years since the discovery of a chromosomal abnormality in CML; the so-called Philadelphia chromosome. Since then genomics has revolutionized cancer care and the impact in hematologic malignancies is plentiful. Healthcare providers must understand the science to be able to apply in practice and communicate complex information to patients and caregivers. This session will provide an overview of foundational genomic concepts and how genomics is applied across the care continuum for hematologic cancers. Case studies examining the application of testing to “real life” situations will be presented and resources for patients will be shared.